{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:20:42Z","timestamp":1790774442858,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002784","name":"Canada Excellence Research Chairs, Government of Canada","doi-asserted-by":"publisher","award":["950-230745"],"award-info":[{"award-number":["950-230745"]}],"id":[{"id":"10.13039\/501100002784","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Toulouse","award":["--"],"award-info":[{"award-number":["--"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Supervised injection facilities have been set-up in many countries to curb the health risks associated with unsafe injection practices. These facilities have, however, been met with vocal opposition, notably in France. As harm reduction policies can only succeed to the extent that people agree with them, this study mapped French people\u2019s opinions regarding the setting-up of these facilities.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>A sample of 318 adults--among them health professionals--were presented with 48 vignettes depicting plans to create a supervised injection facility in their town. Each vignette contained three pieces of information: (a) the type of substance that would be injected in the facility (amphetamines only, amphetamines and cocaine only, or amphetamines, cocaine and heroin), (b) the type of staff who would be working in the facility (physicians and nurses, specially trained former drug users, specially trained current drug users, or trained volunteers recruited by the municipality), and (c) the staff members\u2019 mission (to be present and observe only, technical counselling about safe injection, counselling about safe injection and hygiene, or counselling and encouragement to follow a detoxification program).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Through cluster analysis, three qualitatively different positions were found: Not very acceptable (20%), Depends on staff and mission (49%), and Always acceptable (31%). These positions were associated with demographic characteristics--namely gender, age and political orientation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>French people\u2019s positions regarding supervised injection facilities were extremely diverse. One type of facility would, however, be accepted by a large majority of people: supervised injection facilities run by health professionals whose mission would be, in addition to technical and hygienic counselling, to encourage patrons to enter detoxification or rehabilitation programs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13011-020-00321-2","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T11:02:56Z","timestamp":1602673376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["French People\u2019s positions on supervised injection facilities for drug users"],"prefix":"10.1186","volume":"15","author":[{"given":"Maria Teresa","family":"Munoz Sastre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7002-365X","authenticated-orcid":false,"given":"Lonzozou","family":"Kpanake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Mullet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","unstructured":"Fast D, Small W, Wood E, Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduct J. 2008;5:32.","DOI":"10.1186\/1477-7517-5-32"},{"issue":"8","key":"321_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jama.2019.0095","volume":"321","author":"LO Gostin","year":"2019","unstructured":"Gostin LO, Hodge JG, Gulinson CL. Supervised injection facilities: legal and policy reforms. JAMA. 2019;321(8):745\u20136.","journal-title":"JAMA"},{"key":"321_CR3","first-page":"1","volume":"26","author":"N Lloyd","year":"2016","unstructured":"Lloyd N, St\u00f6ver H, Zurhold H, Hunt N. Similar problems, divergent responses: drug consumption room policies in the UK and Germany. J Subst Use. 2016;26:1\u20135.","journal-title":"J Subst Use"},{"key":"321_CR4","volume-title":"The state of harm reduction in Western Europe","author":"Harm Reduction International","year":"2018","unstructured":"Harm Reduction International. The state of harm reduction in Western Europe. 2018, Retrieved at https:\/\/www.infodrog.ch\/files\/content\/schadensminderung_de\/international\/hri_western-europe_global-state_feb2019_final.pdf."},{"key":"321_CR5","volume-title":"Drug consumption rooms in the Netherlands","author":"A de Gee","year":"2018","unstructured":"de Gee A, van der Gouwe D, Woods S, Charvet C, van der Poel A. Drug consumption rooms in the Netherlands. 2018, Retrieved at https:\/\/www.trimbos.nl\/docs\/eebe7cf1-179d-407b-94d0-8a202d8ec296.pdf."},{"key":"321_CR6","volume-title":"Consumption rooms in Germany","author":"Deutsche AidShilfe","year":"2020","unstructured":"Deutsche AidShilfe. Consumption rooms in Germany. 2020, Retrieved at https:\/\/www.drogenkonsumraum.net\/news\/quantity-and-locations."},{"issue":"5","key":"321_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14(5):161\u201383.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.drugpo.2018.04.014","volume":"56","author":"M Jauffret-Roustide","year":"2018","unstructured":"Jauffret-Roustide M, Cailbault I. Drug consumption rooms: comparing times, spaces and actors in issues of social acceptability in French public debate. Int J Drug Pol. 2018;56:208\u201317.","journal-title":"Int J Drug Pol"},{"issue":"6","key":"321_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/add.12506","volume":"109","author":"C Strike","year":"2014","unstructured":"Strike C, Jairam J, Kolla G, Millson P, Shepherd S, Fischer B, Watson TM, Bayoumi AM. Increasing public support for supervised injection facilities in Ontario, Canada. Addiction. 2014;109(6):946\u201353.","journal-title":"Addiction"},{"issue":"1","key":"321_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.drugpo.2006.12.001","volume":"18","author":"MF Firestone Cruz","year":"2007","unstructured":"Firestone Cruz MF, Patra J, Fischer B, Rehm J, Kalousek K. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy. 2007;18(1):54\u201361.","journal-title":"Int J Drug Policy"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13011-016-0052-7","volume":"11","author":"C Strike","year":"2016","unstructured":"Strike C, Rotondi NK, Watson TM, Kolla G, Bayoumi AM. Public opinions about supervised smoking facilities for crack cocaine and other stimulants. Subst Abuse Treat Prev Policy. 2016;11:8. https:\/\/doi.org\/10.1186\/s13011-016-0052-7.","journal-title":"Subst Abuse Treat Prev Policy."},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1747-597X-8-40","volume":"8","author":"D Tzemis","year":"2013","unstructured":"Tzemis D, Campbell J, Kuo M, Buxton JA. A cross-sectional study of public attitudes towards safer drug use practices in British Columbia, Canada. Subst Abuse Treat Prev Policy. 2013;8:40.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"321_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12954-018-0273-3","volume":"16","author":"SC Mema","year":"2019","unstructured":"Mema SC, Frosst G, Bridgeman J, Drake H, Dolman C, Lappalainen L, Corneil T. Mobile supervised consumption services in rural British Columbia: lessons learned. Harm Reduct J. 2019;16(1):4. https:\/\/doi.org\/10.1186\/s12954-018-0273-3.","journal-title":"Harm Reduct J"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.drugpo.2005.03.003","volume":"16","author":"HH Thein","year":"2005","unstructured":"Thein HH, Kimber J, Maher L, MacDonald M, Kaldor JM. Public opinion towards supervised injecting centres and the Sydney medically supervised injecting Centre. Int J Drug Pol. 2005;16:275\u201380.","journal-title":"Int J Drug Pol."},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13011-015-0022-5","volume":"10","author":"M Kulesza","year":"2015","unstructured":"Kulesza M, Teachman BA, Werntz AJ, Gasser ML, Lindgren KP. Correlates of public support toward federal funding for harm reduction strategies. Subst Abuse Treat Prev Policy. 2015;10:25. https:\/\/doi.org\/10.1186\/s13011-015-0022-5.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ypmed.2018.02.026","volume":"111","author":"EE McGinty","year":"2018","unstructured":"McGinty EE, Barry CL, Stone EM, Niederdeppe J, Kennedy-Hendricks A, Linden S, Sherman SG. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73\u20137.","journal-title":"Prev Med"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2018.10.008","volume":"63","author":"CL Barry","year":"2019","unstructured":"Barry CL, Sherman SG, Stone E, Kennedy-Hendricks A, Niederdeppe J, Linden S, et al. Arguments supporting and opposing legalization of safe consumption sites in the U.S. Int J Drug Policy. 2019;63:18\u201322.","journal-title":"Int J Drug Policy"},{"key":"321_CR18","volume-title":"France, Country Drug Report","author":"European Monitoring Center for Drug and Drug Addiction","year":"2019","unstructured":"European Monitoring Center for Drug and Drug Addiction. France, Country Drug Report 2019. Retrieved at https:\/\/www.emcdda.europa.eu\/publications\/country-drug-reports\/2019\/france_en."},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1360-0443.2001.9645978.x","volume":"96","author":"M Valenciano","year":"2001","unstructured":"Valenciano M, Emmanuelli J, Lert F. Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction. 2001;96:597\u2013606.","journal-title":"Addiction."},{"key":"321_CR20","first-page":"143","volume":"7","author":"P Polom\u00e9ni","year":"2014","unstructured":"Polom\u00e9ni P, Schwan R. (2014). Management of opioid addiction with buprenorphine: French history and current management. Int J Gen Med. 2014;7:143\u20138.","journal-title":"Int J Gen Med"},{"issue":"6","key":"321_CR21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.drugpo.2013.05.008","volume":"24","author":"M Jauffret-Roustide","year":"2013","unstructured":"Jauffret-Roustide M, Pedrono G, Beltzer N. (2013). Supervised consumption rooms: the French paradox. Int J Drug Pol. 2013;24(6):628\u201330.","journal-title":"Int J Drug Pol."},{"issue":"17","key":"321_CR22","first-page":"22","volume":"68","author":"G Waeckerl\u00e9","year":"2017","unstructured":"Waeckerl\u00e9 G. Salles de consommation \u00e0 moindre risque : premier bilan de l\u2019exp\u00e9rimentation strasbourgeoise [Supervised injection facilities : the Strasbourg experiment]. Revue de Formation sur le Risque M\u00e9dical. 2017;68(17):22\u20136.","journal-title":"Revue de Formation sur le Risque M\u00e9dical"},{"key":"321_CR23","volume-title":"Enqu\u00eate EROPP","author":"Observatoire Fran\u00e7ais des Drogues et des Toxicomanies","year":"2010","unstructured":"Observatoire Fran\u00e7ais des Drogues et des Toxicomanies. Enqu\u00eate EROPP (2010). Retrieved at http:\/\/www.ofdt.fr\/BDD\/publications\/docs\/eftajcq8.pdf."},{"issue":"1","key":"321_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/13698575.2017.1291918","volume":"19","author":"G Kolla","year":"2017","unstructured":"Kolla G, Strike C, Watson TM, Jairam J, Fischer B, Bayoumi AM. Risk creating and risk reducing: community perceptions of supervised consumption facilities for illicit drug use. Health Risk Soc. 2017;19(1):91\u2013111.","journal-title":"Health Risk Soc"},{"key":"321_CR25","unstructured":"Spilka S, Le N\u00e9zet O, Janssen E, Brissot A, Philippon A. Les drogues \u00e0 17 ans : analyse r\u00e9gionale [Regional analysis of drug intake at 17 years]. Observatoire Fran\u00e7ais des Drogues et des Toxicomanies, 2018. Retrieved at https:\/\/www.ofdt.fr\/BDD\/publications\/docs\/epfxssy9.pdf."},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"e000774","DOI":"10.1136\/bmjopen-2011-000774","volume":"2","author":"M Taylor","year":"2012","unstructured":"Taylor M, Mackay K, Murphy J, McIntosh A, McIntosh C, Anderson S, Welch K. Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland. BMJ Open. 2012;2:e000774. https:\/\/doi.org\/10.1136\/bmjopen-2011-000774.","journal-title":"BMJ Open"},{"key":"321_CR27","volume-title":"Moral science","author":"NH Anderson","year":"2019","unstructured":"Anderson NH. Moral science. London: Routledge; 2019."},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13011-020-00267-5","volume":"15","author":"S Castani\u00e9","year":"2020","unstructured":"Castani\u00e9 S, Munoz Sastre MT, Kpanake L, Mullet E. Mapping and comparing French people\u2019s positions regarding restrictive control policies: a pilot study. Subst Abuse Treat Prev Policy. 2020;15:25. https:\/\/doi.org\/10.1186\/s13011-020-00267-5.","journal-title":"Subst Abuse Treat Prev Policy."},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11135-011-9529-7","volume":"47","author":"J Hofmans","year":"2013","unstructured":"Hofmans J, Mullet E. Towards unveiling individual differences in different stages of information processing: a clustering-based approach. Qual Quant. 2013;47:555\u201364.","journal-title":"Qual Quant"},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13722-019-0169-x","volume":"14","author":"P Smith","year":"2019","unstructured":"Smith P, Favril L, Delhauteur D, van der Laenen F, Nivaise P. How to overcome political and legal barriers to the implementation of a drug consumption room: an application of the policy agenda framework to the Belgian situation. Addict Sci Clin Pract. 2019;14:40.","journal-title":"Addict Sci Clin Pract"},{"key":"321_CR31","volume-title":"Salles de shoot: Bachelot victime d'un virage \u00e0 droite [Bachelot victim of a change in politics]. L\u2019Express","author":"J Saulnier","year":"2010","unstructured":"Saulnier J. Salles de shoot: Bachelot victime d'un virage \u00e0 droite [Bachelot victim of a change in politics]. L\u2019Express, 2010. Retrieved at https:\/\/www.lexpress.fr\/actualite\/politique\/salles-de-shoot-bachelot-victime-d-un-virage-a-droite_912026.html."},{"key":"321_CR32","volume-title":"Roselyne Bachelot sur RTL. Les salles de shoot sont \"le premier palier pour arr\u00eater la consommation de drogue\" [Supervised injection facilities as a first step to stop illicit drug consumption]","author":"RTL Midi","year":"2012","unstructured":"RTL Midi. Roselyne Bachelot sur RTL. Les salles de shoot sont \"le premier palier pour arr\u00eater la consommation de drogue\" [Supervised injection facilities as a first step to stop illicit drug consumption]. 2012 https:\/\/www.rtl.fr\/actu\/roselyne-bachelot-sur-rtl-les-salles-de-shoot-sont-le-premier-palier-pour-arreter-la-consommation-de-drogue-7753742552."},{"issue":"5","key":"321_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.disamonth.2018.12.002","volume":"65","author":"L Vearrier","year":"2019","unstructured":"Vearrier L. The value of harm reduction for injection drug use: a clinical and public health ethics analysis. Dis Mon. 2019;65(5):119\u201341.","journal-title":"Dis Mon"},{"key":"321_CR34","volume-title":"R\u00e9duction des risques chez les usagers de drogues: Synth\u00e8se et recommandations","author":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","year":"2010","unstructured":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale. R\u00e9duction des risques chez les usagers de drogues: Synth\u00e8se et recommandations. Paris: INSERM; 2010."},{"key":"321_CR35","volume-title":"Drug consumption rooms: an overview of provision and evidence (Perspectives on drugs)","author":"European Monitoring Center for Drug and Drug Addiction","year":"2017","unstructured":"European Monitoring Center for Drug and Drug Addiction. Drug consumption rooms: an overview of provision and evidence (Perspectives on drugs). 2017, Retrieved at https:\/\/www.emcdda.europa.eu\/publications\/pods\/drug-consumption-rooms_en."},{"key":"321_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.drugalcdep.2019.02.006","volume":"197","author":"BCL Lange","year":"2019","unstructured":"Lange BCL, Bach-Mortensen AM. A systematic review of stakeholder perceptions of supervised injection facilities. Drug Alcohol Depend. 2019;197:299\u2013314.","journal-title":"Drug Alcohol Depend"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-020-00321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13011-020-00321-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13011-020-00321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:11:08Z","timestamp":1634170268000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/s13011-020-00321-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1186\/s13011-020-00321-2","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"7 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for the study was granted by the Ethics Committee of the Federal University of Toulouse, France. All participants signed a consent form before completing this survey, and responses were anonymous.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have obtained consent to publish from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}